APO RESEARCH · REPORT
Stem Cell Therapy
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Product & engineering
Understand the product.
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Selected research
Industry Growth & Trends
Global Stem Cell Therapy Industry Growth and Trends Forecast to 2032
Market perspective
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
According to APO Research, the global Stem Cell Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Stem Cell Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Stem Cell Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Stem Cell Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Stem Cell Therapy.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Stem Cell Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Stem Cell Therapy Market by Company
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Medi-post
Anterogen
Molmed
Takeda (TiGenix)
Stem Cell Therapy Segment by Type
Autologous
Allogeneic
Stem Cell Therapy Segment by Application
Musculoskeletal Disorder
Wounds & Injuries
Cornea
Cardiovascular Diseases
Others
Stem Cell Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Stem Cell Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Autologous
- Allogeneic
Applications
- Musculoskeletal Disorder
- Wounds & Injuries
- Cornea
- Cardiovascular Diseases
- Others
Companies covered
- Osiris Therapeutics
- NuVasive
- Chiesi Pharmaceuticals
- JCR Pharmaceutical
- Pharmicell
- Medi-post
- Anterogen
- Molmed
- Takeda (TiGenix)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Stem Cell Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Stem Cell Therapy Market Size by Region (2021-2032)
- 1.4.1 Global Stem Cell Therapy Market Size by Region (2021-2026)
- 1.4.2 Global Stem Cell Therapy Market Size by Region (2027-2032)
- 1.5 Key Regions Stem Cell Therapy Market Size (2021-2032)
- 1.5.1 North America Stem Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Stem Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Stem Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.4 South America Stem Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Stem Cell Therapy Market Size Growth Rate (2021-2032)
2 Stem Cell Therapy Market by Type
- 2.1 Type Introduction
- 2.1.1 Autologous
- 2.1.2 Allogeneic
- 2.2 Global Stem Cell Therapy Market Size by Type
- 2.2.1 Global Stem Cell Therapy Market Size Overview by Type (2021-2032)
- 2.2.2 Global Stem Cell Therapy Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Stem Cell Therapy Market Size Forecasted by Type (2027-2032)
- 2.3 Global Stem Cell Therapy Market Size by Regions
- 2.3.1 North America Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
3 Stem Cell Therapy Market by Application
- 3.1 Type Introduction
- 3.1.1 Musculoskeletal Disorder
- 3.1.2 Wounds & Injuries
- 3.1.3 Cornea
- 3.1.4 Cardiovascular Diseases
- 3.1.5 Others
- 3.2 Global Stem Cell Therapy Market Size by Application
- 3.2.1 Global Stem Cell Therapy Market Size Overview by Application (2021-2032)
- 3.2.2 Global Stem Cell Therapy Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Stem Cell Therapy Market Size Forecasted by Application (2027-2032)
- 3.3 Global Stem Cell Therapy Market Size by Regions
- 3.3.1 North America Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Stem Cell Therapy Industry Trends
- 4.2 Stem Cell Therapy Industry Drivers
- 4.3 Stem Cell Therapy Industry Opportunities and Challenges
- 4.4 Stem Cell Therapy Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Stem Cell Therapy Revenue (2021-2026)
- 5.2 Global Stem Cell Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Stem Cell Therapy Key Company Headquarters & Area Served
- 5.4 Global Stem Cell Therapy Company, Product Type & Application
- 5.5 Global Stem Cell Therapy Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Stem Cell Therapy Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Stem Cell Therapy Players Market Share by Revenue in 2025
- 5.6.3 2025 Stem Cell Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Osiris Therapeutics
- 6.1.1 Osiris Therapeutics Company Information
- 6.1.2 Osiris Therapeutics Business Overview
- 6.1.3 Osiris Therapeutics Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Osiris Therapeutics Stem Cell Therapy Product Portfolio
- 6.1.5 Osiris Therapeutics Recent Developments
- 6.2 NuVasive
- 6.2.1 NuVasive Company Information
- 6.2.2 NuVasive Business Overview
- 6.2.3 NuVasive Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 NuVasive Stem Cell Therapy Product Portfolio
- 6.2.5 NuVasive Recent Developments
- 6.3 Chiesi Pharmaceuticals
- 6.3.1 Chiesi Pharmaceuticals Company Information
- 6.3.2 Chiesi Pharmaceuticals Business Overview
- 6.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Product Portfolio
- 6.3.5 Chiesi Pharmaceuticals Recent Developments
- 6.4 JCR Pharmaceutical
- 6.4.1 JCR Pharmaceutical Company Information
- 6.4.2 JCR Pharmaceutical Business Overview
- 6.4.3 JCR Pharmaceutical Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 JCR Pharmaceutical Stem Cell Therapy Product Portfolio
- 6.4.5 JCR Pharmaceutical Recent Developments
- 6.5 Pharmicell
- 6.5.1 Pharmicell Company Information
- 6.5.2 Pharmicell Business Overview
- 6.5.3 Pharmicell Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Pharmicell Stem Cell Therapy Product Portfolio
- 6.5.5 Pharmicell Recent Developments
- 6.6 Medi-post
- 6.6.1 Medi-post Company Information
- 6.6.2 Medi-post Business Overview
- 6.6.3 Medi-post Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Medi-post Stem Cell Therapy Product Portfolio
- 6.6.5 Medi-post Recent Developments
- 6.7 Anterogen
- 6.7.1 Anterogen Company Information
- 6.7.2 Anterogen Business Overview
- 6.7.3 Anterogen Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Anterogen Stem Cell Therapy Product Portfolio
- 6.7.5 Anterogen Recent Developments
- 6.8 Molmed
- 6.8.1 Molmed Company Information
- 6.8.2 Molmed Business Overview
- 6.8.3 Molmed Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Molmed Stem Cell Therapy Product Portfolio
- 6.8.5 Molmed Recent Developments
- 6.9 Takeda (TiGenix)
- 6.9.1 Takeda (TiGenix) Company Information
- 6.9.2 Takeda (TiGenix) Business Overview
- 6.9.3 Takeda (TiGenix) Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Takeda (TiGenix) Stem Cell Therapy Product Portfolio
- 6.9.5 Takeda (TiGenix) Recent Developments
7 North America
- 7.1 North America Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Stem Cell Therapy Market Size by Country (2021-2026)
- 7.3 North America Stem Cell Therapy Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Stem Cell Therapy Market Size by Country (2021-2026)
- 8.3 Europe Stem Cell Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Stem Cell Therapy Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Stem Cell Therapy Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Stem Cell Therapy Market Size by Country (2021-2026)
- 10.3 South America Stem Cell Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Stem Cell Therapy Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Stem Cell Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst